Asia Deal Watch: Heartseed Licenses Lead Cell Therapy Candidate To Novo Nordisk

 
• By Ian Haydock, Anju Ghangurde, Jung Won Shin, Brian Yang, and Joseph Haas

Novo gets worldwide development and commercial rights except for Heartseed’s home market in Japan. LianBio unveils licensing partnerships with Lyra, Landos and Nanobiotix.

Asia Deal Watch
• Source: Alamy

More from Deals

More from Business